Berkeley Lights

Berkeley Lights, Inc. (BLI) is a digital cell biology company dedicated to developing and commercializing platforms to accelerate the discovery, development, and delivery of cell-based products and therapies. At the intersection of biology, technology, and information, our platform automates the manipulation, analysis, and selection of individual cells, delivering ultimate scalability and deep cellular insights. The Beacon platform is ideally suited for cell line development, antibody discovery (including direct B-cell workflows), gene editing, and antibody engineering workflows. Each workflow achieves 100 times more insight, 10 times faster speed, at a fraction of the cost.